Circulating Follistatin Predicts Tirzepatide Treatment Outcomes on Type 2 Diabetes

被引:0
|
作者
Zou, Qi
Engstrom, Gunnar
Pan, Jingxue
Zhang, Jialin
Perisho, Esther J.
Lin, Yanzhu
Wiese, Russell
Wilson, Jonathan M.
Pavo, Imre
Gao, Rui
Duffin, Kevin L.
De Marinis, Yang
机构
关键词
D O I
10.2337/db24-741-P
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
741-P
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Follistatin-a circulating biomarker for type 2 diabetes
    Wu, C.
    Borne, Y.
    Rodriguez, M. Lopez
    Duffin, K. L.
    Gao, R.
    Melander, O.
    Melander, M. Orho
    Shore, A.
    Khan, F.
    Natali, A.
    Nilsson, J.
    Vaag, A.
    Laakso, M.
    Groop, L.
    De Marinis, Y.
    DIABETOLOGIA, 2019, 62 : S88 - S88
  • [2] Tirzepatide (Mounjaro) for the Treatment of Type 2 Diabetes Mellitus
    Rebitch, Catherine B.
    AMERICAN FAMILY PHYSICIAN, 2023, 108 (01) : 93 - 94
  • [3] Elevated circulating follistatin associates with an increased risk of type 2 diabetes
    Chuanyan Wu
    Yan Borné
    Rui Gao
    Maykel López Rodriguez
    William C. Roell
    Jonathan M. Wilson
    Ajit Regmi
    Cheng Luan
    Dina Mansour Aly
    Andreas Peter
    Jürgen Machann
    Harald Staiger
    Andreas Fritsche
    Andreas L. Birkenfeld
    Rongya Tao
    Robert Wagner
    Mickaël Canouil
    Mun-Gwan Hong
    Jochen M. Schwenk
    Emma Ahlqvist
    Minna U. Kaikkonen
    Peter Nilsson
    Angela C. Shore
    Faisel Khan
    Andrea Natali
    Olle Melander
    Marju Orho-Melander
    Jan Nilsson
    Hans-Ulrich Häring
    Erik Renström
    Claes B. Wollheim
    Gunnar Engström
    Jianping Weng
    Ewan R. Pearson
    Paul W. Franks
    Morris F. White
    Kevin L. Duffin
    Allan Arthur Vaag
    Markku Laakso
    Norbert Stefan
    Leif Groop
    Yang De Marinis
    Nature Communications, 12
  • [4] Circulating Follistatin and Activin A and Their Regulation by Insulin in Obesity and Type 2 Diabetes
    Sylow, Lykke
    Vind, Birgitte F.
    Kruse, Rikke
    Moller, Pauline M.
    Wojtaszewski, Jorgen F. P.
    Richter, Erik A.
    Hojlund, Kurt
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (05):
  • [5] Circulating follistatin as a novel biomarker of type 2 diabetes mellitus risk
    Stella Papachristou
    Djordje S. Popovic
    Nikolaos Papanas
    International Journal of Diabetes in Developing Countries, 2023, 43 : 779 - 780
  • [6] Circulating follistatin as a novel biomarker of type 2 diabetes mellitus risk
    Papachristou, Stella
    Popovic, Djordje S.
    Papanas, Nikolaos
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2023, 43 (05) : 779 - 780
  • [7] Tirzepatide for type 2 diabetes
    Anderson, Sarah L.
    Marrs, Joel C.
    DRUGS IN CONTEXT, 2023, 12
  • [8] Elevated circulating follistatin associates with an increased risk of type 2 diabetes
    Wu, Chuanyan
    Borne, Yan
    Gao, Rui
    Rodriguez, Maykel Lopez
    Roell, William C.
    Wilson, Jonathan M.
    Regmi, Ajit
    Luan, Cheng
    Aly, Dina Mansour
    Peter, Andreas
    Machann, Juergen
    Staiger, Harald
    Fritsche, Andreas
    Birkenfeld, Andreas L.
    Tao, Rongya
    Wagner, Robert
    Canouil, Mickael
    Hong, Mun-Gwan
    Schwenk, Jochen M.
    Ahlqvist, Emma
    Kaikkonen, Minna U.
    Nilsson, Peter
    Shore, Angela C.
    Khan, Faisel
    Natali, Andrea
    Melander, Olle
    Orho-Melander, Marju
    Nilsson, Jan
    Haering, Hans-Ulrich
    Renstrom, Erik
    Wollheim, Claes B.
    Engstrom, Gunnar
    Weng, Jianping
    Pearson, Ewan R.
    Franks, Paul W.
    White, Morris F.
    Duffin, Kevin L.
    Vaag, Allan Arthur
    Laakso, Markku
    Stefan, Norbert
    Groop, Leif
    De Marinis, Yang
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [9] Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspective
    De Block, Christophe
    Bailey, Clifford
    Wysham, Carol
    Hemmingway, Andrea
    Allen, Sheryl Elaine
    Peleshok, Jennifer
    DIABETES OBESITY & METABOLISM, 2023, 25 (01): : 3 - 17